Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry

American Journal of Cardiology

Volumn 77, Issue 11, 1996, Pages 1017-1020

  Shindler, Daniel M ^a   Kostis, John B ^b   Yusuf, Salim ^b   Quinones, Miguel A ^b   Pitt, Bertram ^b   Stewart, Dawn ^b   Pinkett, Tamara ^b   Ghali, Jalal K ^b   Wilson, Alan C ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029893241     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89163-1     Document Type: Article

References (20)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
2. Kessler H. Mortality experience of diabetic patients - a twenty-six year follow-up study. Am J Med 1971;51:715-724.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease; the Framingham study. JAMA 1979;241:2035-2038.
4. The SOLVD Investigators. Studies of Left Ventricular Dysfunction (SOLVD) - rationale, design, and methods. Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990;6:315-322.
5. The SOLVD Investigators. Effect of enatapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
6. The SOLVD Investigators. Effect of enalapril on mortality and in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
7. Bangdiwala SI, Weiner DH, Bourassa MG, Friesinger OC II, Ghali JK, Yusuf S. Studies of Left Ventricular Dysfunction (SOLVD) registry: rationale, design, methods and description of baseline characteristics. Am J Cardiol 1992;70:347-353.
8. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J 1995;130:51-58.
9. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665-669.
10. Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A. Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction. Acta Med Scand 1988;224:31-38.
11. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL. Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985;54:466-472.
12. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984;108:31-37.
13. Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984;54:718-721.
14. Kimmelstiel C, Goldberg RJ. Congestive heart failure in women: focus on heart failure due to coronary artery disease and diabetes. Cardiology 1990;77(suppl 2):71-79.
15. Packer M, Lee WH, Medina N, Yushak M, Kessler PD, Gottlieb SS. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure. Am J Med 1987;82:1119-1126.
16. Kirlin PC, Benedict C, Shelton BJ, Francis G, Nicklas J, Liang CS, Kubo S, Johnstone D, Probstfield J, Yusuf S. Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction. Am J Cardiol 1995;75:354-359.
17. Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang CS, Konstam MA, Greenberg B, et al. Effect of long term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators. Am J Cardiol 1995;75:1151-1157.
18. Sampson MJ, Chambers JB, Sprigings DC, Drury PL. Regression of left ventricular hypertrophy with 1 year of antihypertensive treatment in type 1 diabetic patients with early nephropathy. Diabetic Med 1991;8:106-110.
19. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B. Effects of long term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography study. Circulation 1995;91:2573-2581.
20. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S, Pouleur H, for the SOLVD Investigators. Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD ( Studies of Left Ventricular Dysfunction) Investigators. Circulation 1993;88:2277-2283.